Skip to content

Efficacy of fevogrit in treatment of fever

A clinical study on efficacy of fevogrit in treatment of fever A single arm open label observational study - NA

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/02/063022
Enrollment
100
Registered
2024-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R509- Fever, unspecified

Interventions

None listed

Sponsors

Patanjlai Research Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Both gender with age limit 18 to 60 years Body temperature more than 99°F (37.2°C) Willing to participate and give consent for the study

Exclusion criteria

Exclusion criteria: Subject on antipyretic, antibiotic, and steroidal medication within the previous 8-12 hours Any acute or chronic condition that would limit the ability of the patient to participate in the study (Renal, Cardiac disease, Liver disease, or hematologic disorders, bronchial asthma, peptic ulcer disease, and frequent vomiting) Any condition the investigator identifies that can confound the participants ability to properly participate in the study Pregnancy or lactation, intention to pregnancy Known case of Hypothyroidism & Endocrine disease condition.

Design outcomes

Primary

MeasureTime frame
Reduction in fever in the first four hours after the first dose of fevogritTimepoint: Baseline 1hr 2hr 3hr 4hr 8hr Day 2 Day 3

Secondary

MeasureTime frame
First occurrence of normal temperature Timepoint: Day 1 Day 2 Day 3

Countries

India

Contacts

Public ContactDr Pratibha Rauthan

Patanjali Ayurved Hospital Patnjali Yogpeeth (Trust)

drcbdhanraj@gmail.com7396174582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026